Therapeutic compounds as inhibitors of the orexin-1 receptor
US12024509B2 · kind B2 · utility
0Cited by
20References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2020 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Mar 10, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.